Skip to content
Loading…
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as soon as this quarter.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.